Q&A with N-SIDE’s Sébastien Coppe: how digitisation overcomes clinical bottlenecks
The World Health Organization declared the Covid-19 crisis to be a pandemic in mid-March 2020. Nine months later, three vaccines…
All articles by Allie Nawrat
Allie Nawrat
-
-
Treatment-resistant rare diseases: exploring landmark drug approvals in 2020
Drug development is extremely challenging no matter the condition – nine in ten drugs fail in clinical trials. However, this…
-
Coronavirus company news summary
16 April 2020 Japan’s Fujifilm has expanded manufacturing capacity to boost production of its influenza drug Avigan that is being…
-
Aligos to leverage Luxna’s tech to create anti-viral drugs
Aligos Therapeutics has broadened its license agreement with Osaka University's Luxna Biotech to develop anti-viral drugs against the virus causing…
-
Exploring efficiencies from eTMF with Cancer Research UK
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) defines a trial master file (TMF) as “the story of how…
-
FDA accepts BLA from AstraZeneca and Daiichi for targeted chemotherapy
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has accepted their biologics license application…
-
Combining antibiotics with immune response to treat antibiotic resistant bacteria
Researchers from Lehigh University in the US have designed a new possible solution for antibiotic resistant bacteria by combining antibiotics…